Therefore, targeting GRP94 in macrophages may prove to be an attractive strategy for the treatment of colon cancer by regulating the Wnt and inflammatory signaling in the tumor microenvironment. This evidence concerns the gene HSP90B1 and malignant colon neoplasm.